Biodefense

Current NIAID Biodefense Research Funding Opportunities

Clinical Evaluation

Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Relevant Dates: Sept. 12, 2008
Focus: To support the design and conduct of Phase III and/or Phase IV clinical trials of new strategies for the use of licensed, off-patent antimicrobial therapies to reduce the risk of antimicrobial resistance in selected infectious diseases.
Contact Info
Frank Vidergar
E-mail: vidergarf@niaid.nih.gov

Clinical Trial Planning (R34) Grants PAR-06-384

Standard receipt dates
Focus: To support clinical trials planning (R34) grants for complete planning and design of, and documentation for, investigator-initiated Phase I, II, III, and IV clinical trials on biomedical or behavioral interventions, including drugs, treatments, devices, and novel methods.
Contact Info 
Karen Reese (DAIDS)
E-mail: kreese@niaid.nih.gov
Josiah Wedgwood (DAIT)
E-mail: jwedgwood@niaid.nih.gov
Shy Shorer (DMID)
E-mail: shorers@niaid.nih.gov